P-gp inhibitor 5
Modify Date: 2024-01-12 14:45:54
P-gp inhibitor 5 structure
|
Common Name | P-gp inhibitor 5 | ||
|---|---|---|---|---|
| CAS Number | 2451298-06-7 | Molecular Weight | 517.98 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H20ClNO5S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of P-gp inhibitor 5P-gp inhibitor 5 (compound 10) is a potent P-glycoprotein (P-gp) inhibitor with P-gp inhibition fold of 2.5 and 3.0 at 1.25 μM and 2.5 μM. P-gp inhibitor 5 has antiproliferative activity against certain cancer cell lines. P-gp inhibitor 5 is effective in reversing the multidrug resistance (MDR) phenotype in ABCB1/Flp-InTM-293 and KBvin cells by restoring their sensitivity to Vincristine and Paclitaxel[1]. |
| Name | P-gp inhibitor 5 |
|---|
| Description | P-gp inhibitor 5 (compound 10) is a potent P-glycoprotein (P-gp) inhibitor with P-gp inhibition fold of 2.5 and 3.0 at 1.25 μM and 2.5 μM. P-gp inhibitor 5 has antiproliferative activity against certain cancer cell lines. P-gp inhibitor 5 is effective in reversing the multidrug resistance (MDR) phenotype in ABCB1/Flp-InTM-293 and KBvin cells by restoring their sensitivity to Vincristine and Paclitaxel[1]. |
|---|---|
| Related Catalog | |
| Target |
P-gp[1] |
| In Vitro | P-gp inhibitor 5 (compound 10) has cytotoxic against ABCB1/Flp-InTM-293 and KBvin cells with IC50s of 29.7 and 12.6 μM, respectively[1]. P-gp inhibitor 5 (2.5 and 5 μM) lows the IC50s of KBvin cells for Vincristine to 7.59~36.82 nM, for Paclitaxel to 21.0~79.5 nM, for Doxorubicin to 85.7~111 nM; lows the IC50s of HeLaS3 cells for Vincristine to 2.24~3.91 nM, for Paclitaxel to 8.81~9.58 nM, for Doxorubicin to 102~1260 nM[1]. |
| References |
| Molecular Formula | C28H20ClNO5S |
|---|---|
| Molecular Weight | 517.98 |